Susquehanna International Group, LLP Provention Bio, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$6.7 - $24.21 $1.67 Million - $6.02 Million	248,847 Added 216.56%	363,758 $8.77 Million
Q4 2022 Feb 14, 2023	SELL	$4.52 - $10.57 $308,395 - $721,180	-68,229 Reduced 37.26%	114,911 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $336,284 - $550,996	98,042 Added 115.21%	183,140 $824,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $114,610 - $229,220	31,400 Added 58.48%	85,098 $340,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $470,957 - $1.09 Million	-138,517 Reduced 72.06%	53,698 $393,000
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $568,721 - $751,851	101,739 Added 112.45%	192,215 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $1.26 Million - $1.86 Million	-223,098 Reduced 71.15%	90,476 $579,000
Q2 2021 Aug 11, 2021	BUY	$6.71 - $11.04 $439,236 - $722,678	65,460 Added 26.38%	313,574 $2.64 Million
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $515,988 - $991,697	50,987 Added 25.87%	248,114 $2.6 Million
Q4 2020 Feb 16, 2021	BUY	$11.79 - $18.94 $498,492 - $800,802	42,281 Added 27.31%	197,127 $3.34 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $379,974 - $558,569	36,748 Added 31.12%	154,846 $1.99 Million
Q2 2020 Aug 14, 2020	SELL	$7.81 - $17.0 $1.88 Million - $4.09 Million	-240,503 Reduced 67.07%	118,098 $1.67 Million
Q1 2020 May 15, 2020	BUY	$5.42 - $17.75 $857,709 - $2.81 Million	158,249 Added 78.99%	358,601 $3.3 Million
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $924,273 - $2.36 Million	158,266 Added 376.05%	200,352 $2.99 Million
Q3 2019 Nov 14, 2019	BUY	$6.83 - $13.0 $111,684 - $212,576	16,352 Added 63.54%	42,086 $287,000
Q2 2019 Aug 16, 2019	BUY	$2.3 - $13.79 $6,626 - $39,728	2,881 Added 12.61%	25,734 $311,000
Q2 2019 Aug 14, 2019	BUY	$2.3 - $13.79 $52,561 - $315,142	22,853 New	22,853 $277,000

Others Institutions Holding PRVB

# of Institutions

Shares Held

170K

Call Options Held

Put Options Held

Odey Asset Management Group LTD London, X0

170K
Shares

$0
1.36% of portfolio

View Full List

About Provention Bio, Inc.

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

More about PRVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account